Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

New study shows neurophysiological impacts of psychotherapy

The use of cognitive-behavioural therapy to treat tics in Tourette syndrome may be as effective as and even superior to medication in certain cases.

15 Apr 2011

Catherine Zeta Jones treated for bipolar disorder

Catherine Zeta Jones – the 41-year-old Welsh actor checked into a day clinic in Connecticut for five days earlier this month for the treatment of bipolar disorder. “After dealing with the stress of the past year, Catherine made the decision to check in to a mental health facility for a brief stay to treat her Bipolar II Disorder,” said publicist Cece Yorke said in a statement adding, “She's feeling great and looking forward to starting work this week on her two upcoming films.”

13 Apr 2011

Scientists discover how anti-depressants make new brain cells

For the first time in a human model, scientists have discovered how anti-depressants make new brain cells. This means that researchers can now develop better and more efficient drugs to combat depression.

12 Apr 2011

Rockefeller University professor earns recognition in developmental psychobiology

Weill Cornell Medical College and the Columbia University College of Physicians and Surgeons have announced that The Mortimer D. Sackler, M.D. Prize for Distinguished Achievement in Developmental Psychobiology has been awarded to The Rockefeller University's Dr. Fernando Nottebohm for his seminal work in songbirds that has led to the discovery of neuronal replacement.

12 Apr 2011

Alzheimer’s drug – a failure of sorts: Study

Results from the study shows that drug, memantine, is no better than a dummy pill when it comes to ameliorating disease symptoms, including the decline of mental abilities and also helping patients with moderate Alzheimer's, the researchers say. Sold under the brand Namenda by Forest Laboratories Inc and Germany's Merz Pharma, the drug had U.S. sales of about $1.2 billion last year.

11 Apr 2011

Gilenya can reduce risk of disability progression in patients with RRMS

A new analysis demonstrated that Gilenya reduced the risk of disability progression in patients with relapsing-remitting multiple sclerosis, regardless of treatment history. This analysis of the phase III two-year FREEDOMS study is one of 11 abstracts on Gilenya being presented at the 63rd annual meeting of the American Academy of Neurology.

11 Apr 2011

Study: Unemployment linked to high risk of death in men than women

In a meta-analysis of 42 studies with data on 20 million people regarding the relationship between unemployment and the risk of death, a team of researchers at Stony Brook University found that the risk of death was 63 percent higher in those who experienced an episode of unemployment than those who did not.

11 Apr 2011

VHS Group sponsors 2011 International Health Risk Management Forum

Sponsored by Valurise Health Solutions International, and guided/supported by the Chinese workers' mutual Insurance Association All-China Federation of Trade Unions, the China Insurance Association and the International Disease Management Alliance, the 2011 International Health Risk Management Forum, Opportunity and Challenge of Health Risk Management in the Transition Period in China is going to be held on 20th April, 2011 in the National Convention Centre in Beijing, China.

8 Apr 2011

John Wiley hosts Psychology Roundtable

On Thursday, March 31, John Wiley & Sons, Inc. hosted a Wiley Psychology Roundtable focused on developmental psychology, entitled Putting Research into Practice. The invitation-only forum, held at the 2011 Society for Research and Child Development Biennial Meeting in Montreal, was a dynamic discussion about the needs and methods of making research in developmental psychology more accessible.

8 Apr 2011

Antidepressant medication improves physical recovery from stroke

A University of Iowa study finds that patients treated with a short course of antidepressants after a stroke have significantly greater improvement in physical recovery than patients treated with a placebo. Moreover, the study is the first to demonstrate that this physical recovery continues to improve for at least nine months after the antidepressant medication is stopped.

8 Apr 2011

Targacept's TC-5619 Phase 2 trial data in schizophrenia presented at ICOSR

Targacept, Inc. today announced the presentation of data from a Phase 2 clinical proof of concept trial to assess TC-5619 as an augmentation therapy to improve cognition in patients with schizophrenia at the International Congress on Schizophrenia Research in Colorado Springs, Colorado.

8 Apr 2011

Patients with stroke can benefit from antidepressants

8 Apr 2011

Sibling ‘squabbles’ good for the youngest child: Study

According to the latest research from the University of Cambridge sibling rivalry and fighting between siblings increase the social skills, vocabulary and emotional development of younger brothers and sisters. They found that the competitiveness acquired from regular tiffs with the elder sibling may make the second child more popular and successful at school, and in later life.

7 Apr 2011

CoMeD urges UN to ban mercury use in pharmaceuticals

While the United Nations actively questions the use of a vaccine preservative that contains the known neurotoxin mercury, the Coalition for Mercury-Free Drugs, a Maryland-based, non-profit organization, is urging the UN to ban it.

7 Apr 2011

Biological Psychiatry publishes Omeros' PPAR-gamma addiction program

Omeros Corporation today announced that research on the PPAR-gamma agonists it is developing in its Addiction franchise has been published in the April 1, 2011 issue of the Journal of Biological Psychiatry.

7 Apr 2011

Persistent fatigue in breast cancer survivors may be caused by autonomic nervous system running in overdrive

The persistent fatigue that plagues one out of every three breast cancer survivors may be caused by one part of the autonomic nervous system running in overdrive, while the other part fails to slow it down.

7 Apr 2011

Molecular switch regulating protein behavior increases human susceptibility to schizophrenia, mood disorders

Johns Hopkins researchers report the discovery of a molecular switch that regulates the behavior of a protein that, when altered, is already known to increase human susceptibility to schizophrenia and mood disorders.

7 Apr 2011

Work, social and family disability affect 50% of patients with bipolar disorder

Such was the conclusion obtained in a study conducted at the University of Granada that was recently awarded a prize in the IV Spain-Portugal Meeting on Therapeutical Adherence held in Oporto.

6 Apr 2011

ABAM accredites 10 new addiction training programs for physicians

The American Board of Addiction Medicine Foundation today accredited 10 training programs, the nation's first post-graduate addiction medicine residencies for physicians. The Foundation also released its Program Requirements and Curriculum Objectives, national guidelines for addiction medicine residencies.

6 Apr 2011

Study finds marked increases in teen use of marijuana and Ecstasy

Following a decade of steady declines, a new national study released today by The Partnership at Drugfree.org and MetLife Foundation indicates that teen drug and alcohol use is headed in the wrong direction, with marked increases in teen use of marijuana and Ecstasy over the past three years.

6 Apr 2011